Histone H3 lysine 9 trimethylation (H3K9Me3) has been associated with transcriptional repression, but recent findings implicate this chromatin modification in transcriptional activation and mRNA elongation by RNA polymerase II. Here, we applied immunoprecipitation (IP) with a custom DNA tiling microarray containing many transcription factors important in development and cancer (for example homeotic genes; N ¼ 683 total genes) to explore the relationship between H3K9Me3 and other histone modifications with the differential expression of genes. Cancer cell lines derived from different tissues (2 leukemia, 2 medulloblastoma) were characterized with IP antibodies to H3K9Me3, H3K4 dimethylation (H3K4Me2) and H3K9 acetylation (H3K9Ac). MV4-11 is known to overexpress the HOXA9 and MEIS1 genes, whereas D283 overexpresses the OTX2 homeobox gene. Gene expression was assessed by Affymetrix U133 array. Mapping the number and size of histone markings demonstrated significant colocalization of H3K9Ac and H3K4Me2 with H3K9Me3, indicating a pattern of putative 'activating' and 'repressive' markings. The median site size was 600-821 bp and 72-95% or 53-80% of chromatin signal sites were located within 1 kb or 500 bp of transcription start sites (TSS), respectively. A relatively small number of genes displayed additional H3K9Me3 sites in the 5 0 -region distant from the TSS. Comparing genes with modification sites to those without sites in their promoters confirmed the positive associations of H3K9Ac and H3K4Me2 with gene expression and revealed that H3K9Me3 is associated with active genes rather than being a repressive marking as previously thought. The positive regulatory effect of all three types of modifications were quantitatively correlated with site size, and applied to absolute gene expression within a single cell line as well as relative expression among pairs of cell lines. Extended patterns of H3K9Me3 upstream of some genes (for example HOXA9 and OTX2) may result from the action of multiple promoter elements. We found an inverse relationship between promoter DNA hypermethylation and H3K9Me3 in three studied genes (HOXA9, TMS1, RASSF1A). The localization of H3K9Me3 downstream of the TSSs of expressed genes and not within promoter regions of hypermethylated and silenced genes is consistent with the proposed coupling of H3K9Me3 with RNA polymerase II. Our results indicate a need for revising aspects of the histone code involving H3 lysine methylation. Awareness of H3K9Me3 as a mark of gene activity, not repression, is especially important for the classification of human cancer using chromatin and histone profiles.
Histone H3 lysine 9 trimethylation (H3K9Me3) has been associated with transcriptional repression, but recent findings implicate this chromatin modification in transcriptional activation and mRNA elongation by RNA polymerase II. Here, we applied immunoprecipitation (IP) with a custom DNA tiling microarray containing many transcription factors important in development and cancer (for example homeotic genes; N ¼ 683 total genes) to explore the relationship between H3K9Me3 and other histone modifications with the differential expression of genes. Cancer cell lines derived from different tissues (2 leukemia, 2 medulloblastoma) were characterized with IP antibodies to H3K9Me3, H3K4 dimethylation (H3K4Me2) and H3K9 acetylation (H3K9Ac). MV4-11 is known to overexpress the HOXA9 and MEIS1 genes, whereas D283 overexpresses the OTX2 homeobox gene. Gene expression was assessed by Affymetrix U133 array. Mapping the number and size of histone markings demonstrated significant colocalization of H3K9Ac and H3K4Me2 with H3K9Me3, indicating a pattern of putative 'activating' and 'repressive' markings. The median site size was 600-821 bp and 72-95% or 53-80% of chromatin signal sites were located within 1 kb or 500 bp of transcription start sites (TSS), respectively. A relatively small number of genes displayed additional H3K9Me3 sites in the 5 0 -region distant from the TSS. Comparing genes with modification sites to those without sites in their promoters confirmed the positive associations of H3K9Ac and H3K4Me2 with gene expression and revealed that H3K9Me3 is associated with active genes rather than being a repressive marking as previously thought. The positive regulatory effect of all three types of modifications were quantitatively correlated with site size, and applied to absolute gene expression within a single cell line as well as relative expression among pairs of cell lines. Extended patterns of H3K9Me3 upstream of some genes (for example HOXA9 and OTX2) may result from the action of multiple promoter elements. We found an inverse relationship between promoter DNA hypermethylation and H3K9Me3 in three studied genes (HOXA9, TMS1, RASSF1A). The localization of H3K9Me3 downstream of the TSSs of expressed genes and not within promoter regions of hypermethylated and silenced genes is consistent with the proposed coupling of H3K9Me3 with RNA polymerase II. Our results indicate a need for revising aspects of the histone code involving H3 lysine methylation. Awareness of H3K9Me3 as a mark of gene activity, not repression, is especially important for the classification of human cancer using chromatin and histone profiles.
Introduction
Aberrant gene expression in human cancer is thought to be mediated in part through post-translational modifications of histone and other DNA binding proteins, which alter the functional properties of chromatin (Gregory and Shiekhattar, 2004) . Covalent modifications of histone H3 have been widely studied as pivotal in the regulation of gene transcription. A 'histone code' hypothesis has evolved to explain how combinations of modifications affect transcriptional regulation (Strahl and Allis, 2000; Turner, 2000) . In mammals, histone H3 lysine 9 acetylation (H3K9Ac) and H3 lysine 4, 36 and 79 methylation are linked with active transcription, whereas methylation of histone H3 lysine 9, 27 and histone H4 lysine 20 are associated with transcriptionally silent heterochromatin. The division of chromatin patterns into exclusive active and repressive domains has been questioned by recent studies. For example, human T cells display both H3K9 acetylation and H3K27 trimethylation among many transcribed genes (Roh et al., 2006) . Expressed genes in human (Azuara et al., 2006) and mouse (Bernstein et al., 2006) embryonic stem cells were identified that displayed both activating and repressive histone markings. The latter study termed these seemingly conflicting histone patterns 'bivalent' chromatin structures (Bernstein et al., 2006) . Recently, Vakoc et al. (2005) presented a surprising finding that H3K9Me3 was present in the transcribed region of eight genes that they examined. This observation seems at variance with the well described association of H3K9Me3 with both constitutive (Peters et al., 2003) and facultative heterochromatin (Heard et al., 2001) . Vakoc et al. (2005) further reported that heterochromatin protein 1g (HP1g), which contains a chromo-domain predicted to recognize H3K9 methylation, is also present in the transcribed region and may form a complex with RNA polymerase II. Importantly, they demonstrated the specificity of the antibodies they used in their chIP experiments and ruled out cross-reactivity of H3K9Me3 with other markings that could have produced spurious results. These and other observations indicate that RNA polymerase II associates with chromatin modifications that include histone H3K9 methylation, a mark most commonly associated with gene silencing (Eissenberg and Shilatifard, 2006) . A subsequent report showed that H4K20 monomethylation, another modification linked with repression, may also be a mark of transcript elongation (Vakoc et al., 2006) .
Here, we tested whether H3K9Me3 is associated with differentially expressed genes in human cancer cells and specifically genes that control the action of many transcription factors responsible for maintaining the differentiated state of cells. We examined the relationship of H3K9Me3 with H3K4Me2 and H3K9Ac modifications in human cancer cell lines using chromatin immunoprecipitation and a custom-designed DNA tiling microarray (ChIP-on-chip). The array interrogates 5 kb upstream and 1 kb downstream of the TSS of 683 genes including all known homeodomain transcription factors and many other cancer association genes (for example MAGE genes). The 5 0 -location of probes allows us to examine whether H3K9Me3 is restricted to the regions around and downstream of TSSs as predicted (Vakoc et al., 2005 (Vakoc et al., , 2006 . Gene expression was assessed by the Affymetrix HGU133 Plus 2.0 expression microarray. We examined two cell lines in depth: MV4-11 and D283, both of which overexpress homeobox genes. MV4-11 is a biphenotypic leukemic cell that contains a t(4;11) translocation and resultant fusion protein that activates the mixed lineage leukemia (MLL) gene (Canaani et al., 2004) . MLL is homologous to the Drosophila Trithorax chromatin modifying genes that encode proteins with histone H3K4 methyltransferase activity. MLL rearrangements led to many fold overexpression of the HOXA9 and MEIS1 genes (Rozovskaia et al., 2001; Armstrong et al., 2002; Yeoh et al., 2002) . The medulloblastoma cell line D283 represents the classic histopathological subtype of these tumors that contain an amplified OTX2 homeobox gene (Boon et al., 2003 (Boon et al., , 2005 Acampora et al., 2005; de Haas et al., 2006) . OTX2 is an essential transcriptional factor in the development of the central nervous system (Kimura et al., 2005; Vernay et al., 2005; Rath et al., 2006) . Results from D283 were also contrasted with Daoy, a cell line isolated from the nodular/desmoplastic subtype of medulloblastoma. Nodular medulloblastoma rarely displays OTX2 amplification and overexpression and are associated with a different age at onset, tumor location and survival times compared with classic or anaplastic types (de Haas et al., 2006 Table 2 . Using ChIP-on-chip analyses that interrogated promoter regions covering upstream 5 kb and downstream 1 kb of 683 genes, we found that all three histone modifications overlapped significantly with the TSS of genes on our platform, with 72-95 or 53-80% of chromatin signal sites were located within 1 kb or 500 bp of TSSs, respectively. The three modifications have similar size distributions with medians ranging from 600 to 821 bp. Results illustrating these findings for the MV4-11 cell line are depicted in Figure 1 . Note that the site size can be regarded as a surrogate measure for the strength, or more precisely, the extensiveness of the chromatin modification, since they were defined by neighboring, statistically significant probes in IPenriched DNA compared to the input controls (see Materials and methods for the exact definition). For each of the histone markings there was an apparent decreased signal intensity immediately upstream of the TSS. Similar results were obtained with Rch, D283 and Daoy (data not shown). The smoothed curve in panel d of Figure 1 shows a subtle difference in the distribution of the histone marks with slightly more H3K9Ac and H3K4Me2 signals being located 3 0 to TSSs compared with H3K9Me3.
H3K9Me3, H3K4Me2 and H3K9Ac modifications overlap each other
We calculated the relative location of histone markings with respect to each other in order to test whether two markings occupied the same genomic location or whether one marking occurs upstream (5 0 ) or downstream (3 0 ) another marking. Results are presented for the MV4-11 cell line in Figure 2 . A symmetrical distribution indicates no bias with respect to the location of one marker versus another. Panel a shows the distribution of differences in site location for doublepositive sites (measured at the midpoint of the site) for all three possible combinations of bivalent markings. The relative site distributions indicated that most sites are colocalized although some differences are suggested. The distribution of relative locations of H3K4Me2 and H3K9Ac appeared the most symmetrical in these analyses, suggesting no systematic difference in the position of one mark relative to the other. Some shifts are indicated for the relative locations of H3K9Me3 with respect to either H3K9Ac or H3K4Me2. These distributions were somewhat skewed in the direction indicating that H3K9Me3 sites were located downstream of H3K9Ac or H3K4Me2 sites. Interestingly, even though K9Me3 sites are on average shorter than K9Ac and K4Me2 sites (Figure 1 , with median sizes at 680, 742.5, 722 bp respectively for MV4-11), H3K9Me3 sites appeared to be larger than H3K9Ac or H3K4Me2 sites when they co-localize ( Figure 2 ). This suggests an interaction, likely to be H3K9Me3 dominant, between H3K9Me3 and other active markings.
Gene expression is strongly associated with H3K9Me3 site occurrence, size and distance from the TSS There were 669 genes on our panel that were also represented on the expression array. We first tested whether the presence of H3K9Me3 was associated with the log2 intensity for genes on the Affymetrix array. In panel a of Figure 3 , we show representative results in the MV4-11 cell line. The presence of a positive site for H3K9Me3 (>4-fold IP/input signal and Po0.0001) was significantly associated with increased gene expression (Wilcoxon P-value o10 À5 ). To test whether proximity of H3K9Me3 to the TSS was associated with expression level, we evaluated the trend between site location and log2 intensity using Pearson's correlation. Panel b reveals an increasing trend in expression with proximity to gene TSSs (Po10 À5 ). Correlation analysis shown in panel c also demonstrated a significant association of H3K9Me3 site size with log2 intensity (Pearson's correlation Po10 À5 ). Significant associations were seen in all cell lines tested for each type of analysis shown in panels a-c.
Differential gene expression is marked by H3K9Me3 site presence and size
In addition to the above observation that H3K9Me3 is associated with active expression in a signal-dependent manner within a cell line, we hypothesize that histone modifications can also be predictive of active gene expression when comparing the relative expression of a gene with different cells. Figure 4 illustrates such a positive association by comparing the two medulloblastoma cell lines Daoy and D283. When stratified by the presence or absence of significant H3K9Me3 sites within 1 kb of a gene TSS in Daoy and D283 using a stringent criteria (>4-fold IP/input intensity and Po0.0001) into four groups, it is apparent that genes have relatively higher expression in the cell line where H3K9Me3 sites are present ( differentially expressed genes (panel a). D283 overexpresses MAGEA6 84-fold compared with MV4-11 and showed large and continuous co-localized acetylation and methylation signals around the TSS and extending 1 kb downstream. The HOXA9 gene was overexpressed 91-fold in MV4-11 compared with D283 and contained extensive H3K9Ac and three large H3K9Me3 sites extending up to À4 kb. Panel b depicts the consensus TSS; another highly conserved distal promoter is known to exist at about À4.5 kb. High and uniform H3K9Ac signal intensity covered the 5 0 -region, whereas H3K9Me3 signals were interrupted by low-intensity regions just upstream of the TSS and À1.5 to À2.5 kb. Panel c demonstrates another example of co-localized H3K9Me3 and H3K9Ac around and downstream of the TSS. Here, CD44 is expressed 14-fold greater in Daoy compared with D283. Both marks extend beyond exon 1 of CD44. GATA-6 in panel d represents a third type of H3K9Me3 pattern. The relative expression of GATA-6 is 40-fold in Daoy compared with D283. Highly significant acetylation and methylation modifications are evident around the GATA-6 TSS and downstream in the initial 1 kb transcribed region, but also evident are upstream sites that overlap an antisense transcribed gene AK123079. The upstream 5 0 H3K9Me3 sites show local peaks within exons 1 and 2 of AK123079. In addition to CD44, other genes marked by H3K9Me3 and overexpressed in Daoy compared with D283 are several potential therapeutic targets: MAGEA11 (40-fold), MAGEB2 (37-fold), CAV1 and 2 (26-fold) and EGFR (12-fold).
QPCR confirms ChIP-on-chip H3K9Me3 presence in HOXA9, MEIS1 and OTX2 We confirmed our tiling array experiments by carrying out single gene ChIP studies. Figure 6 summarizes our comparisons between MV4-11 and D283 for the HOXA9 (panel a) MEIS1 (panel b) and OTX2 genes (panel c). We confirmed that H3K9Me3 was increased around the TSS and downstream region for each gene as predicted by the ChIP-on-chip results. These studies extended the regions beyond those on the array and revealed that for HOXA9 and MEIS1 significant H3K9Me3 can be found 1.7 and 2.3 kb downstream each gene, respectively. We assessed in some detail the upstream 5 0 -region of the OTX2 gene. H3K9Me3 extended from the location of the distal promoter (TSSb) through the proximal promoter locations (TSSa À4.8 kb). ChIP-on-chip profiles revealed H3K9Me3 extended over the first exonic regions of OTX2 as well (data not shown). The amplified OTX2 locus contained the largest regions of H3K9Me3 modification we observed in the present study.
Inverse relationship between promoter DNA hypermethylation and H3K9Me3 We compared our ChIP-on-chip results for H3K9Me3 and other marks with DNA hypermethylation status to see if H3K9Me3 was present in promoter regions of methylated and silenced genes. The results for three genes (HOXA9, TMS1 and RASSF1A) are shown in Supplementary Table 4 . Using quantitative methylation-specific PCR, we found each gene to be hypermethylated in D283 but not methylated in MV4-11. Gene-expression data confirmed that the non-methylated genes were many fold overexpressed in MV4-11 compared with those that were methylated in D283. Also, H3K9Me3 was accompanied by strong H3K9Ac and H3K4Me2 signals in MV4-11. These results are consistent with H3K9Me3 being a mark of active gene expression and not a mark of gene silencing, at least for these three genes.
Discussion
Our DNA tiling array was designed to interrogate 5 kb of the 5 0 -region of our candidate genes and 1 kb downstream of each gene's TSS. The rationale for this design was that if H3K9Me3 were a suppressive chromatin marking, then it would be detected in the 5 0 -regions of transcriptionally silent genes. In contrast to this situation our major finding is that the H3K9Me3 marking is detectable by ChIP-on-chip analysis among many genes expressed in cancer cells within genomic regions overlapping known histone activating signals. Using a sliding window approach, we found that H3K9Ac and H3K4Me2 sites associated with gene transcription overlapped with sites containing significant H3K9Me3 enrichment in about 80% of cases of positive sites. For genes containing all three markings, we found that modification sites overlapped within 1 kb of the TSS in about 90% of genes. These results are consistent with the previous assignment of H3K9Ac and H3K4Me2 to 0.5 kb of either side of the TSS of expressed genes (Liang et al., 2004) . Our single gene ChIP confirmed the tiling array data in revealing robust H3K9Me3 signals among highly expressed genes such as HOXA9, MEIS1 and OTX2 in cells overexpressing these genes. In their first study Vakoc et al. (2005) H3K9Me3 markings in the polyA binding protein gene (Vakoc et al., 2006) and that regions of hyperacetylated histone H3 were relatively devoid of H3K9Me3. There was a suggestion from our results in MV4-11 that H3K9Me3 signals may be more 3 0 compared with H3K9Ac or H3K4me2 although the significant overlap of H3K9Me3 with these modifications is the most prominent feature of our data. There are limitations in localizing these signals with all ChIP methods given the shearing of DNA to about 200-1000 bp. In addition, for ChIP-on-chip studies the tiling array probe spacing and the sliding window scoring method also limit resolution. Nonetheless, our finding of H3K9Me3 among regions at or up to 1 kb downstream of the TSS strongly indicates that H3K9Me3 is abundant within the initial transcribed regions of differentially expressed genes. Interestingly, the distribution of histone markings immediately upstream of the TSS was suggestive of a local decrease in signal intensity for all markings (Figure 1 ). Such a decrease may result from nucleosome depletion among gene promoters undergoing activation (Boeger et al., 2003; Bernstein et al., 2004) .
Our results also indicated that for some highly expressed cancer-associated genes such as HOXA9, OTX2 and GATA-6 there are additional sites of H3K9Me3 within very broad regions of 5 0 modification. These upstream modifications associated with transcription may represent upstream multiple start sites for gene transcription, the presence of different genes in close proximity or other unidentified RNA products (for example regulatory RNA). In the case of HOXA9 and OTX2 it seems most likely that alternative TSSs could explain the presence of these distal modifications. For example, three major HOXA9 transcripts (a9a, a9b, a9T), which are highly conserved between species have been identified and the long a9a transcript is regulated through a start site approximately 4.5 kb upstream of the consensus TSS. Our finding of extended 5 0 markings in HOXA9 is consistent with previous ChIP experiments showing that the MLL fusion protein leads to broadly distributed histone activation marks (that is H3K4Me3, H3K9Ac) across the entire HOXA9 locus encompassing all three transcripts (Milne et al., 2005) . Our results add H3K9Me3 as being abundant over the HOXA9 locus in MLL-positive leukemia cells. The OTX2 locus encodes two major isoforms that are regulated by a proximal promoter approximately 4.8 kb downstream of a second upstream promoter (Fossat et al., 2005) . In mice it has been shown that as embryonic neurodevelopment proceeds, there is a time-dependent shift toward the utilization of the distal promoter (Fossat et al., 2005) . Two additional TSSs have also been detected with one being upstream about 2.2 kb and an additional proximal site (Acampora et al., 2005) . Our ChIP results indicated strong H3K9Me3 modification across a broad area encompassing the predicted initial transcribed portions associated with both the distal and proximal OTX2 promoters; the strongest signals were located in the region between the two in an area corresponding to the second distal TSS. This may indicate that the amplification of OTX2 and many fold overexpression of the gene involves the action of multiple OTX2 promoters. ChIPon-chip scans demonstrated H3K9Me3 deposited throughout the exonic regions as well. The GATA-6 gene was overexpressed 40-fold in Daoy compared with D283 and contained strong H3K9Me3 signals around the TSS as well as 1-2 kb 5 0 -upstream. These upstream markings do not correspond to known GATA-6 TSSs but are near the TSS of a newly described antisense expressed sequence AK123079. Multiple promoter usage and closely spaced or antisense transcribed gene sequences should be considered in the interpretation of ChIP-on-chip chromatin profiles.
Previous studies indicated a tight linkage between CpG island methylation, histone H3 lysine 9 methylation The graphs show fold difference (IP/In) þ standard error for three separate experiments, with each PCR run done in triplicate. Genes assayed are: (a) HOXA9; (b) MEIS1; and (c) OTX2, including two isoforms noted as TSSa and TSSb. Numbering (x ¼ 0) for OTX2 is relative to the upstream promoter location TSSb (Fossat et al., 2005) . and transcriptional silencing (Bird, 2002; Richards and Elgin, 2002; Kondo et al., 2003 Kondo et al., , 2004 . Reversal of gene silencing by the demethylating agent 5Aza-dC was shown to lead to the disappearance of histone H3 lysine methylation (Nguyen et al., 2002; Kondo et al., 2004; Zhao et al., 2005) . Our results could appear to contradict these observations as we found that in D283 the HOXA9, TMS1 and RASSF1A loci were hypermethylated and nonexpressed but we were unable to detect the presence of any H3K9Me3. In contrast, these three genes are expressed and display strong H3K9Me3 signals in the MV4-11 cell line. A possible explanation for these differences is that earlier studies used IP antibodies specific for histone H3K9Me2 in contrast to the present work, which focused on H3K9Me3. Thus, while histone H3K9Me2 and H3K9Me3 are dynamic intermediates of different methylated states they appear to mark very different functional chromatin domains Di-and trimethyl histone lysine 9 were found to reside as stable methylation states within different chromatin sites (Wu et al., 2005) . Our study cannot provide further insights on this point as we did not carry out ChIP experiments using anti-H3K9Me2-specific antibodies.
In addition to its physical association with RNA polymerase II, Vakoc et al. (2005) confirmed the presence of H3K9Me3 within heterochromatic major satellite repeats. H3K9Me3 modifications may be unique among histone methylation modifications in being associated with both heterochromatin and actively transcribed genes (Eissenberg and Shilatifard, 2006 ). An intriguing aspect of this dual localization is the association of H3K9Me3 with the heterochromatin binding protein HP1g (Vakoc et al., 2005) , which unlike HP1a or HP1b is found in euchromatin as well as heterochromatin (Minc et al., 2000) . HP1g is present in mammals but not in the widely studied fission yeast. Recent studies suggest phosphorylation of HP1g at Ser 83 is responsible for targeting the protein to euchromatin and it's binding to the Ku70 protein (Lomberk et al., 2006) . There are no known functional roles for H3K9Me3 and HP1g in transcribing genes although it has been suggested that the presence of H3K9Me3 may prevent cryptic promoter elements from becoming aberrantly activated following the passage of RNA polymerase II (Vakoc et al., 2006) . Neither the present results nor previous reports can establish whether H3K9Me3 is a 'normal' counterpart in the transcription of all genes or whether it may signify an aberrant readout of the histone code that is more common in cancer cells. Although nontransformed cells have been found to exhibit H3K9Me3 marking within actively transcribed genes, we note here that some differentially expressed genes did not contain H3K9Me3 (Figure 4, panel a) . Hence, H3K9Me3 may not be universally associated with transcription and further studies are required to define the generalizability of our observations more globally among normal and malignant cells.
Implications of our study are several fold. First, because most signals were detected within 1 kb of the TSS, future tiling array designs that target activating histone modifications may be abbreviated to these regions. Farther upstream signals (that is 2-5 kb) were detected only rarely, but notably were present among very highly expressed genes containing multiple transcription initiation sites. Second, our results may help to inform efforts to use ChIP-on-chip for tumor classification. Surveying the chromatin status of important transcriptional regulators such as the homeodomain family of genes could aid in understanding the genesis of specific cancer cell types, in developing new therapies and guiding patient stratification in clinical trials. The subtype of medulloblastoma characterized by OTX2 overexpression and extensive chromatin modifications has recently been shown to be responsive to all trans retinoic acid-induced apoptosis (Acampora et al., 2005) whereas nodular/desmoplastic tumor types, which do not overexpress OTX2, are not responsive. In the Daoy cell line, CD44, CAV 1 and 2, EGFR and several MAGE genes were overexpressed and contained high H3K9Me3 levels compared with D283; all these genes have been considered potential therapeutic targets (Chomez et al., 2001; Annabi et al., 2005; Arslan et al., 2006; Jin et al., 2006; Tijink et al., 2006) .
Future clinical applications of chromatin activity profiling requires a clear definition of the nature of histone alterations that signal 'active' and 'repressed' chromatin patterns. Our results add new insights into the complex relationship between histone modifications and gene expression that highlight the difficulty in assigning chromatin activity to specific markings. The present work strengthens the link between H3K9Me3 and the previously established histone lysine marks such as H3K36Me2 and H3K72Me2 (Miao and Natarajan, 2005) with actively transcribed genes. Our results emphasize the fact that H3K9Me3 is not a suitable marker for classifying genic regions associated with transcriptional repression.
Materials and methods

Cell lines
Cell lines were obtained from the American Type Tissue Culture Association. D283 and Daoy are derived from medulloblastomas; MV4-11 and RcH are acute leukemic cell lines. Cells were cultured in RPMI-1640, 10% fetal calf serum and 5% CO 2 at 371C.
Chromatin immunoprecipitation, amplicon labeling and hybridization Cells were harvested, and chromatin was formalin crosslinked and sheared to approximately 200-1000 bp using a Sonic Dismembrator model 550 at settings 1.5, for 2-4 cycles 50 s per cycle on ice. We followed the microarray application protocol as described in the Chromatin Immunoprecipitation Assay Kit (Upstate cat. #17-295) to isolate chromatin DNA complexes. We used the EZ-ChIP Kit (Upstate cat no 17-371) for single gene confirmatory ChIP. We used ChIP grade antibodies to H3K9Me3 (Abcam Inc., Cambridge, UK, ab 8898), H3K9Ac (Abcam, ab4441) and H34Me2 (Upstate, Lake Placid, NY, USA cat no 07-030). The anti-H3K9Me3 antibody was previously shown not to crossreact with H3K4Me2 epitopes (Vakoc et al., 2005) . Chromatin was also purified from crosslinked DNA that had not been immunoprecipitated; this served as an input DNA control for tiling arrays, which was co-hybridized to provide a reference (that is, total input amplicon). To prepare samples for array hybridization, we applied the method developed in Bing Ren's laboratory to carry out ligation-mediated PCR amplification of ChIP DNA (Boeger et al., 2003) . At least 4 mg of ligation-mediated PCRamplified DNA was used to carry out the subsequent labeling and hybridization steps. The IP amplicon was labeled with Cy5, and an equal amount of the total input amplicons labeled with Cy3; the two are combined to hybridize to the tiling array. Details of the tiling array can be found at NimbleGen.org.
ChIP on chip microarray design, Gene-expression studies-RNA isolation on Affymetrix Plus 2.0. ChIP on chip microarray data analysis: normalization probe annotation site detection and characterization; characterization and summary of sites can be found in Supplementary Table 6 . Normalized log2 ratios are shown in Supplementary Table 3 .
Correlation between sites and expression. With the modified site data and matching mRNA expression data, we can test the association of each site with gene expression; 669 of the 683 genes have probe sets on the HGU133 plus 2.0 arrays based on the UCSC Genome Browser mapping and Affymetrix's probe set annotation, and all site-expression analyses were done for this set of genes. The basic strategy is to compare the relative expression changes with two cell lines, such as MV4-11 vs D283, in relation to their histone modification patterns such as the presence/absence of H3K9Ac. If H3K9Ac represents an 'on' signal for genes, then we would expect to see positive M MV vs D283 ¼ log 2 (MV/D283) for genes with H3K9Ac sites in MV4-11 but not D283, negative M MV vs D283 for genes with sites in D283 but not MV4-11, and no effect for genes with H3K9Ac sites in neither or both cell lines. There are 14 genes with no Affymetrix probe set: BARHL2, FLJ40321, FOXD4L3, FOXD4b, IRX6, LOC120237, LOC257468, MA-GEB10, TGIF2LX, VAX1, WNT3A, FLJ27255, LOC402176 and LOC494141. Note that only one Affymetrix probe set per gene was chosen for site-expression analysis even though many genes map to multiple probe sets. For genes with multiple probe sets, we chose the most 'informative' probe set, as defined by the intensity range across the four cell lines under study to be the representative probe set.
Single gene ChIP using quantitative real-time PCR DNA samples from antibody-bound and input chromatin were analysed by real-time PCR using SYBR Green detection and the 7900HT Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). Primers were designed to interrogate several regions around the TSSs of the HOXA9, MEIS1 and OTX2 genes. Primer sequences and amplicon locations are available on request. Reaction conditions were used as recommended by the manufacturer and as determined by experimental optimization (Power SYBR Green master mix, 100 or 200 nM of each primer, 0.5 mL template DNA diluted 1:5, 10 mL reaction volume) with a two-step PCR cycle (1 Â 95 1C for 10 min.; 40 Â 95 1C for 15 s, 60 1C for 60 s). We calculated the fold difference of a target sequence in the immunoprecipitation (IP) fraction versus a fixed amount of the input DNA (In) using the following expression: Fold increase ¼ 2
ÀðCT;IPÀCT;InÞ . See Supplementary Table 2 for raw data and Table 5 for PCR primers and amplicon locations for Figure 6 .
Quantitative methylation-specific PCR See Supplementary Table 4 for results and Table 5 for methods.
Abbreviations
ChIP, chromatin immunoprecipitation; H3K9Me3, histone 3 lysine 9 trimethylation; MAGE, melanoma antigen gene; TSS, transcription start site.
